The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.

Diastolic dysfunction increasingly is recognized as an important cause of congestive heart failure (CHF). In this study, Mayo Clinic researchers surveyed a random sample of 2042 adults (age ...

HS-135 is under clinical development by 35Pharma and currently in Phase I for Diastolic Heart Failure (HFpEF).

and objective evidence of left ventricular diastolic dysfunction or raised left ventricular filling pressures. In these patients, the ruling out of potential mimickers such as respiratory disease ...

Community-based studies revealed a higher prevalence of LV systolic and diastolic dysfunction using the new echocardiographic imaging techniques. Future prospective studies will clarify the ...

Compared with AS alone, coexisting ATTR-CA was associated with an increased risk of mortality (HR 1.3, 95% CI 1.1-1.4) in a ...

Left-sided heart failure has two main types: systolic failure and diastolic failure. In systolic heart failure, the heart's left lower chamber doesn't contract well, which reduces its force for ...

A study has revealed a new risk factor for heart disease that transcends traditional measures such as body mass index (BMI).

The Heartscape'25 was organized by the unit of cardiovascular and perfusion technology, Yenepoya School of Allied Health ...

Kumamoto University study shows yellow oyster mushroom benefits heart health in mice Mushroom powder enhances cardiovascular ...

Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent ...

The BriefPhillip Allen of Newport Richey became the 100th heart transplant recipient, and the first of 2025, at a Largo ...